- Entry
- $12.76
- Now
- $10.83 -15.1%
- Target
- $18.00
- Score
- —
Helus is the cheapest late-stage psychedelic developer by a wide margin and is currently trading quite below my assessed value (risk-adjusted DCF plus a verified transaction layer); the value is bimodal and the mid-November readout is the focus. Please dig holes but I am really confident, and I wanted to share my thesis below. Esp on today's sell off on XBI - i think it's the right time to make some short term to medium term gains, a minimum double …
— ORIGINAL POST ·
Helus Pharma (HELP): a broad-label psychedelic, one pivotal readout from a massive re-rating
· r/pennystocks
· Aug 28, 2026